All Pharma News
Lisata and Qilu Treat First Patient in LSTA1 Pancreatic Cancer Trial

Lisata and Qilu Treat First Patient in LSTA1 Pancreatic Cancer Trial
GLOBENEWSWIRE
23 Apr 2024
Share Share
Lisata Therapeutics Announces FDA Orphan Drug Designation Granted to LSTA1

Lisata Therapeutics Announces FDA Orphan Drug Designation Granted to LSTA1
GLOBENEWSWIRE
09 Apr 2024
Share Share
Lisata to Participate in Upcoming April 2024 Industry and Investor Events

Lisata to Participate in Upcoming April 2024 Industry and Investor Events
GLOBENEWSWIRE
03 Apr 2024
Share Share
Lisata clinches rare disease status for osteosarcoma drug

Lisata clinches rare disease status for osteosarcoma drug
Akosua Mireku PHARMACEUTICAL TECHNOLOGY
22 Mar 2024
Share Share
Lisata Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1

Lisata Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1
GLOBENEWSWIRE
21 Mar 2024
Share Share
Lisata Reports Full Year 2023 Financial Results and Provides Business Update

Lisata Reports Full Year 2023 Financial Results and Provides Business Update
GLOBENEWSWIRE
29 Feb 2024
Share Share
Lisata Therapeutics to Host Year-End 2023 Conference Call

Lisata Therapeutics to Host Year-End 2023 Conference Call
GLOBENEWSWIRE
22 Feb 2024
Share Share
Lisata Therapeutics to Present at BIO CEO & Investor Conference

Lisata Therapeutics to Present at BIO CEO & Investor Conference
GLOBENEWSWIRE
20 Feb 2024
Share Share
Lisata Therapeutics to Present at the Sequire Investor Summit in Puerto Rico

Lisata Therapeutics to Present at the Sequire Investor Summit in Puerto Rico
GLOBENEWSWIRE
18 Jan 2024
Share Share
Lisata Announces First Patient Treated in the Phase 2a Trial of LSTA1

Lisata Announces First Patient Treated in the Phase 2a Trial of LSTA1
GLOBENEWSWIRE
17 Jan 2024
Share Share